Brigham and Women's Hospital-ko ikertzaileekin lankidetzan egindako argitalpenak (16)

2022

  1. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

    Blood, Vol. 140, Núm. 11, pp. 1200-1228

2021

  1. COVID-19 infection in patients with mast cell disorders including mastocytosis does not impact mast cell activation symptoms

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 9, Núm. 5, pp. 2083-2086

  2. Proceedings from the Inaugural American Initiative in Mast Cell Diseases (AIM) Investigator Conference

    Journal of Allergy and Clinical Immunology

2017

  1. Advances in the classification and treatment of mastocytosis: Current status and outlook toward the future

    Cancer Research, Vol. 77, Núm. 6, pp. 1261-1270

  2. Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions

    Oncotarget, Vol. 8, Núm. 43, pp. 73483-73500

2016

  1. Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; The American Academy of Allergy, Asthma & Immunology; And the European Academy of Allergology and Clinical Immunology

    Journal of Allergy and Clinical Immunology, Vol. 137, Núm. 1, pp. 35-45

2015

  1. KIT mutation analysis in mast cell neoplasms: Recommendations of the European Competence Network on Mastocytosis

    Leukemia, Vol. 29, Núm. 6, pp. 1223-1232

2014

  1. Integrating sequence and array data to create an improved 1000 Genomes Project haplotype reference panel

    Nature Communications, Vol. 5

  2. Proposed diagnostic algorithm for patients with suspected mastocytosis: A proposal of the European Competence Network on Mastocytosis

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 69, Núm. 10, pp. 1267-1274

  3. Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): A consensus proposal

    Annals of Oncology, Vol. 25, Núm. 9, pp. 1691-1700

2013

  1. International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosis

    Blood, Vol. 121, Núm. 13, pp. 2393-2401

2012

  1. An integrated map of genetic variation from 1,092 human genomes

    Nature, Vol. 491, Núm. 7422, pp. 56-65

  2. Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: A consensus proposal

    International Archives of Allergy and Immunology, Vol. 157, Núm. 3, pp. 215-225

2008

  1. Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis

    Journal of Allergy and Clinical Immunology, Vol. 121, Núm. 2, pp. 519-526

2007

  1. Standards and standardization in mastocytosis: Consensus statements on diagnostics, treatment recommendations and response criteria

    European Journal of Clinical Investigation, Vol. 37, Núm. 6, pp. 435-453

2002

  1. Mastocytosis: Current concepts in diagnosis and treatment

    Annals of Hematology, Vol. 81, Núm. 12, pp. 677-690